BOT botanix pharmaceuticals ltd

BOT - Anything but charting, page-9799

  1. 2,662 Posts.
    lightbulb Created with Sketch. 1948

    Market is definitely forward facing - that's why BOT is priced in the 30's even though it isn't making money yet (other than a few hundred grand in royalties).
    That's why as they announce progression towards actual sales, the SP will go up that bit more, each time. And yes, FOMO will play a part in that - just not in a big way for BP I suspect - yet!

    Whilst Japan is an easy starting point, compare SB sales with Qbrexza sales there, and extrapolate both to the US market. Simply put, the US is not translating those same sales figures for Japan Qbrexza in the US. So the question is - will Sofdra?

    BOT will/do have a superior platform and sales strategy, aided by a huge war chest, so I am sure the numbers will be demonstrated, but like I said, BP want certainty. It's no skin off their nose to buy late and make only 30% for shareholders compared to buying too early and potentially losing money for their SH's (even if potentially there was a 300% profit).
    Last edited by Grainofsand: 22/08/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
15.5¢
Change
-0.010(6.06%)
Mkt cap ! $303.9M
Open High Low Value Volume
17.0¢ 17.0¢ 15.5¢ $2.048M 12.88M

Buyers (Bids)

No. Vol. Price($)
41 2125231 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 1374370 19
View Market Depth
Last trade - 16.14pm 11/07/2025 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.